Keswani Sanjay Chandru has filed 4 insider transactions across 1 company since June 2025.
Most recent transaction: a grant/award of 35827 shares of NEUROCRINE BIOSCIENCES INC ($NBIX) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Keswani Sanjay Chandru | Chief Medical Officer | A | Stock Option | 35827 | $0.00 | 35,827.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Keswani Sanjay Chandru | Chief Medical Officer | A | Restricted Stock Unit | 6285 | $0.00 | 6,285.0000 | 102,500,000 | 9999.99% | 0.01% |
| June 2, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Keswani Sanjay Chandru | Chief Medical Officer | A | Restricted Stock Unit | 12846 | $0.00 | 12,846.0000 | 103,700,000 | 9999.99% | 0.01% |
| June 2, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Keswani Sanjay Chandru | Chief Medical Officer | A | Stock Option | 70101 | $0.00 | 70,101.0000 | 103,700,000 | 9999.99% | 0.07% |